跳至主要内容
临床试验/NL-OMON21334
NL-OMON21334尚未招募不适用

Early pharmacological intervention to prevent delirium: Haloperidol prophylaxis in older emergency department patients.

VU Univeristy Medical Center Amsterdam0 个研究点目标入组 600 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
600

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients age 70 years or over;
  • 2. First presentation in the ED in the last month;

排除标准

  • 1. Patients presenting in the ED with delirium according to the DSM-IV criteria;
  • 2. Patients with clinically significant cardiac disorders:

研究者

发起方
VU Univeristy Medical Center Amsterdam

相似试验

已完成
不适用
Early pharmacological intervention to prevent delirium: HAlopeRidol PrOphylaxis in Older emergency department patieNts. The HARPOON studyacute state of confusiondelier10012221Delirium
NL-OMON39657Vrije Universiteit Medisch Centrum780
进行中(未招募)
不适用
An early treatment with haloperiodl to prevent acute confusion in older patients who are acutely admitted to the hospital.Delirium
EUCTR2011-004762-15-NLVU Univeristy Medical Centre
已完成
4 期
Haloperidol Prophylaxis in Older Emergency Department PatientsDelirium
NCT01530308Amsterdam UMC, location VUmc242
已完成
不适用
Early Detection and Pharmacological Intervention for exercise-induced or cold-pressor-induced PHexercise-induced pulmonary hypertension, cold-pressor-induced pulmonary hypertension
JPRN-UMIN000029928Mie University Graduate School of Medicine Department of Cardiology and Nephrology50
进行中(未招募)
不适用
A new therapeutic approach to prevent acute complications in type 2 diabetes: The effect of the combination of the GLP-1 Analog Liraglutide and Insulin LEvemir® against the cOnventional insulin therapy: GALILEOdiabetes mellitus type 2, inadequate metabolic control, indication for insulin therapymyocardial lipid accumulation and left-ventricular function, retinal changes, microabluminuria, beta-cell-function, endothelial dysfunctionMedDRA version: 14.1Level: PTClassification code 10012607Term: Diabetes mellitus inadequate controlSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: PTClassification code 10012689Term: Diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 14.1Level: HLTClassification code 10012654Term: Diabetic complications cardiovascularSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: PTClassification code 10012647Term: Diabetic cardiomyopathySystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1Level: HLTClassification code 10012658Term: Diabetic complications renalSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: HLTClassification code 10012657Term: Diabetic complications ophthalmicSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: PTClassification code 10054044Term: Diabetic microangiopathySystem Organ Class: 10047065 - Vascular disordersMedDRA version: 14.1Level: HLGTClassification code 10012653Term: Diabetic complicationsSystem Organ Class: 10014698 - Endocrine disorders
EUCTR2012-001208-39-ATMedizinische Universität Wien, Univ.Klinik für Innere Medizin III, Abt.f.Endokrinologie und Stoffwechsel